Liver Health Patient Education Guide: Fatty Liver, Hepatitis, Cirrhosis, Liver Transplant and Liver Cancer

Patient Education Series: Five Essential Liver Health Topics

1. Fatty Liver Disease: India’s Silent Epidemic

What Is Fatty Liver Disease?

Non-Alcoholic Fatty Liver Disease, commonly known as fatty liver, is a condition in which excess fat accumulates in liver cells in people who drink little or no alcohol. Once considered a disease of the West, it has now become one of the most prevalent liver conditions in India, silently affecting an estimated one in three adults in urban populations.

At Apollo Hospitals, we are witnessing this shift firsthand. Patients who come in for routine health check-ups are increasingly found to have fatty liver on ultrasound, even though most of them have no symptoms at all. This is precisely what makes the condition dangerous: it can progress quietly over years, often going undetected until significant liver damage has occurred.

Why Are Indians Particularly Vulnerable?

Indians carry a unique biological risk. We tend to accumulate visceral fat, the fat stored around internal organs, at lower body weights compared to Western populations. This means that even a person with a seemingly normal Body Mass Index may have fatty liver if their waist circumference is high.

The Indian diet, which is often high in refined carbohydrates, sugar, and processed foods, combined with increasingly sedentary lifestyles, has created the perfect storm. Add to this the rising rates of Type 2 diabetes and metabolic syndrome, and it becomes clear why fatty liver has reached epidemic proportions in our country.

Stages of Fatty Liver

Fatty liver is not a single condition. It is a spectrum that can progress over time if not addressed.

• Simple Steatosis: Fat accumulation in liver cells without inflammation. This stage is largely reversible with lifestyle changes.
• NASH: Non-Alcoholic Steatohepatitis refers to fat accumulation along with inflammation and liver cell injury. This is a more dangerous stage that can silently progress to fibrosis.
• Fibrosis and Cirrhosis: Scarring of the liver tissue. At this stage, liver function begins to decline, and the risk of liver failure and liver cancer increases significantly.

Diagnosis: What Tests Are Required?

A liver ultrasound is often the first step and can detect moderate to severe fatty liver. However, it cannot accurately quantify the degree of fat or assess fibrosis.

At Apollo Hospitals, we use FibroScan, a non-invasive and painless test that measures liver stiffness and fat content precisely. This helps us stratify risk without a biopsy in most cases. Blood tests, including liver function tests, fasting insulin levels, lipid profile, and HbA1c, are equally important in building a complete metabolic picture.

Treatment and the Path to Recovery

The good news is that fatty liver is one of the few liver conditions that can be significantly reversed with targeted lifestyle modification. Weight loss of just 7–10% of body weight has been shown to dramatically reduce liver fat and inflammation.

A diet low in refined sugars and rich in vegetables, whole grains, and healthy fats, combined with 150 minutes of moderate exercise per week, forms the cornerstone of treatment. For patients with NASH and significant fibrosis, emerging pharmacological therapies may also be considered. Regular follow-up with a hepatologist is essential to monitor progression and prevent complications.

Fatty liver detected early is a disease that can be reversed. Fatty liver ignored is a disease that can silently damage your liver. At Apollo Hospitals, our hepatology team is dedicated to detecting it early and guiding patients back to health.

2. Liver Transplantation: When Is It Needed and What to Expect?

By Dr. Pathik Parikh | Consultant Hepatologist and Liver Transplant Physician, Apollo Hospitals

The Gift of a Second Life

Liver transplantation is one of medicine’s most remarkable achievements. It is a surgical procedure that can replace a failing liver with a healthy one, restoring life to patients who would otherwise have no remaining treatment options.

At Apollo Hospitals, our liver transplant programme brings together world-class surgical expertise, advanced intensive care, and compassionate patient support to deliver outcomes that match the best centres globally. Yet, for most patients and families, the idea of a liver transplant can feel overwhelming. There may be concerns about the surgery, finding a donor, recovery, and life after transplantation. Our goal is to demystify this journey because an informed patient is an empowered patient.

When Is a Liver Transplant Necessary?

A liver transplant is recommended when the liver has lost so much function that it can no longer support life. The most common indications include:

• End-stage cirrhosis: This may occur due to viral hepatitis, alcoholic liver disease, fatty liver disease, or other causes.
• Acute liver failure: A sudden and severe loss of liver function that may result from drug toxicity, viral infections, or autoimmune hepatitis.
• Hepatocellular carcinoma: Liver cancer that meets transplant criteria and has not spread beyond the liver.
• Metabolic liver diseases: Inherited conditions such as Wilson’s disease, primary hyperoxaluria, or certain storage disorders.

The severity of liver disease is measured using the MELD score, which stands for Model for End-Stage Liver Disease. A higher MELD score indicates more severe disease and greater urgency for transplant.

Living Donor Versus Deceased Donor Transplant

In India, the majority of liver transplants are performed using a living donor, typically a close relative who donates a portion of their liver. This is possible because the liver has a unique ability to regenerate. Both the donor’s remaining liver and the recipient’s new graft grow back to near-normal size within weeks.

At Apollo Hospitals, our living donor evaluation programme is thorough and rigorous. We ensure that every donor is fully informed, medically fit, and giving consent freely. Donor safety remains our foremost priority.

What Does the Transplant Journey Look Like?

The process begins with a comprehensive evaluation of the recipient to confirm transplant candidacy, assess surgical risk, and optimise their medical condition. At the same time, the donor undergoes detailed assessment, including blood group compatibility, liver volumetry, and vascular anatomy evaluation.

The surgery itself typically takes 10–14 hours for the recipient and 6–8 hours for the donor, performed by dedicated surgical teams working simultaneously. Post-operative care in a specialised liver transplant ICU is intensive during the first week, followed by a carefully monitored hospital stay of two to three weeks.

Life After Transplant

Life after a successful liver transplant is genuinely transformative. The vast majority of patients return to normal, productive lives. Immunosuppressant medications are required lifelong to prevent rejection, but these medicines are generally well tolerated and managed carefully with regular follow-up.

Most patients are able to return to work within three to six months. A liver transplant is not the end of a chapter; it is the beginning of a new one. Our team walks with every patient through that journey, from the day of listing to years of follow-up care.

3. Hepatitis B and C in India: The Hidden Burden We Must Address

By Dr. Pathik Parikh | Consultant Hepatologist and Liver Transplant Physician, Apollo Hospitals

A Public Health Crisis in Plain Sight

India bears a disproportionately large burden of viral hepatitis. Hepatitis B affects an estimated 40 million Indians, making our country one of the largest reservoirs of the virus in the world. Hepatitis C affects another 6–12 million people. Together, these two viruses are responsible for a large proportion of cirrhosis and liver cancer cases seen in clinics every day.

What makes this crisis particularly painful is that both Hepatitis B and Hepatitis C are largely preventable, and Hepatitis C is now completely curable. Yet millions of Indians remain undiagnosed, unaware that a virus may be quietly damaging their liver over decades.

Hepatitis B: A Lifelong Companion That Can Be Controlled

Hepatitis B is caused by the Hepatitis B Virus, transmitted through blood, sexual contact, or from an infected mother to her newborn at birth. Most adults who acquire Hepatitis B clear the infection on their own. However, when infection occurs in infancy or childhood, which is common in India, it frequently becomes chronic.

Chronic Hepatitis B does not always cause symptoms. Many patients feel perfectly well for years while the virus silently inflames the liver. Over time, this can lead to cirrhosis, liver failure, and hepatocellular carcinoma, one of the most common and aggressive liver cancers.

The good news is that Hepatitis B can be effectively suppressed with oral antiviral medications. These are usually once-daily tablets that reduce the viral load to undetectable levels and dramatically reduce the risk of cirrhosis and cancer. Vaccination prevents new infections entirely, and India’s universal vaccination programme has made great progress, although a large unvaccinated adult population still exists.

Hepatitis C: A Disease We Can Now Cure

Hepatitis C is one of the greatest success stories in modern medicine. Until a decade ago, treatment involved months of painful injections, limited success, and significant side effects. Today, Direct-Acting Antiviral medications can cure over 97% of Hepatitis C patients with just 8–12 weeks of once-daily oral tablets and minimal side effects.

Hepatitis C is transmitted primarily through blood. Historically, this occurred through unscreened blood transfusions, sharing of needles, and unsafe medical practices. Unlike Hepatitis B, there is no vaccine for Hepatitis C, making diagnosis and treatment the only path to elimination.

Who Should Get Tested?

Screening for Hepatitis B and Hepatitis C is recommended for people who may be at increased risk.

• Anyone born to a mother with Hepatitis B
• People who received blood transfusions before routine screening was implemented
• Healthcare workers with potential blood exposure
• People with elevated liver enzymes on routine blood tests
• Anyone with a family history of liver disease or liver cancer

Our Approach at Apollo Hospitals

Our hepatology team at Apollo Hospitals offers comprehensive viral hepatitis care, from accurate diagnosis using sensitive molecular tests to individualised treatment planning, monitoring, and long-term surveillance for patients with established liver damage. We also run dedicated Hepatitis C cure programmes designed to be accessible and affordable.

A single blood test is all it takes to find out if you have Hepatitis B or C. If you have it, a cure or effective control is within reach. Please do not wait.

4. Cirrhosis of the Liver: Understanding, Managing, and Living Well

By Dr. Pathik Parikh | Consultant Hepatologist and Liver Transplant Physician, Apollo Hospitals

What Is Cirrhosis?

Cirrhosis is the final common pathway of long-term liver injury. When the liver is repeatedly damaged by viral hepatitis, alcohol, fatty liver disease, or other causes, it attempts to repair itself by forming scar tissue. Over years, this scar tissue gradually replaces normal liver cells, distorting the liver’s architecture and impairing its function. This irreversible scarring is what we call cirrhosis.

In India, cirrhosis is far more common than most people realise. A significant proportion of patients arrive at clinics only when complications have already developed. This is why public awareness about early detection, timely treatment, and lifestyle modification is so important.

Causes of Cirrhosis in India

The most common causes of cirrhosis seen at Apollo Hospitals include:

• Chronic Hepatitis B: One of the leading causes of cirrhosis in India.
• Alcoholic Liver Disease: A growing burden, particularly among younger men.
• Non-Alcoholic Steatohepatitis: Rapidly rising due to the obesity and diabetes epidemic.
• Chronic Hepatitis C: A treatable cause of long-term liver injury.
• Autoimmune Hepatitis and other less common causes: These require specialised diagnosis and treatment.

Recognising the Symptoms

Early cirrhosis is often asymptomatic and may be discovered incidentally on ultrasound or blood tests. As the disease progresses, patients may notice fatigue, loss of appetite, and unintentional weight loss.

When cirrhosis becomes decompensated, meaning the liver can no longer maintain its essential functions, more serious complications may emerge.

• Ascites: Fluid accumulation in the abdomen, causing abdominal distension and discomfort.
• Variceal bleeding: Enlarged blood vessels in the oesophagus or stomach may rupture, causing potentially life-threatening bleeding.
• Hepatic encephalopathy: Toxin build-up in the blood may affect brain function, causing confusion and altered consciousness.
• Jaundice: Yellowing of the skin and eyes due to impaired bilirubin clearance.

The MELD Score and Monitoring

The MELD score, or Model for End-Stage Liver Disease score, is a number that reflects the severity of liver disease. At Apollo Hospitals, we use this score along with clinical assessment to guide treatment decisions, including when to consider liver transplant listing.

Regular monitoring with liver function tests, endoscopy, ultrasound, and tumour markers allows us to detect and manage complications before they become life-threatening.

Management and Treatment

While cirrhosis itself cannot be reversed once established, its progression can often be halted and complications can be managed effectively. Treating the underlying cause is the most important intervention. This may include suppressing Hepatitis B, curing Hepatitis C, or achieving complete abstinence from alcohol.

A low-sodium diet, diuretics for ascites, and endoscopic band ligation for varices are among the tools used to manage complications. For patients with advanced cirrhosis and deteriorating liver function, liver transplantation offers the only definitive cure by replacing the scarred liver with a healthy one and restoring quality of life.

Living with cirrhosis requires partnership between the patient, family, and a hepatologist who understands the case closely. At Apollo Hospitals, that partnership is at the heart of care.

5. Liver Cancer: Catching Hepatocellular Carcinoma Early Saves Lives

By Dr. Pathik Parikh | Consultant Hepatologist and Liver Transplant Physician, Apollo Hospitals

The Challenge of Hepatocellular Carcinoma

Hepatocellular carcinoma, or HCC, is cancer that originates from liver cells. It is among the most serious complications of chronic liver cirrhosis, Hepatitis B infection, and increasingly, NASH-related liver disease.

What makes HCC particularly challenging is that it often develops silently within a liver that is already diseased. By the time symptoms appear, the tumour has frequently reached an advanced stage where curative options are limited. This is why early detection through structured surveillance is not merely recommended; it is life-saving.

Globally, liver cancer ranks among the leading causes of cancer-related death. In India, it disproportionately affects patients with underlying liver disease.

Who Is at Risk?

Not every liver disease patient carries the same risk of HCC. The highest-risk groups include:

• Patients with cirrhosis of any cause, which is the most important risk factor
• Patients with chronic Hepatitis B infection, even without cirrhosis, particularly if there is a family history of HCC
• Patients with Hepatitis C-related cirrhosis
• Patients with alcoholic cirrhosis or NASH cirrhosis
• Men over 40 with chronic Hepatitis B who have high viral loads

The Surveillance Programme

At Apollo Hospitals, all high-risk patients are enrolled into a structured HCC surveillance programme. This involves an ultrasound of the liver and a serum AFP, or Alpha-Fetoprotein, blood test every six months.

When performed consistently, surveillance can detect tumours at early, treatable stages and improve long-term survival. When ultrasound findings are suspicious, contrast-enhanced CT or MRI of the liver using specific liver protocols is performed. HCC has a characteristic imaging signature that allows diagnosis without biopsy in most cases.

Treatment Options: From Curative to Palliative

The treatment of HCC depends on the stage of the tumour, the underlying liver function, and the patient’s overall health. At Apollo Hospitals, our multidisciplinary tumour board, comprising hepatologists, liver surgeons, interventional radiologists, and oncologists, meets regularly to formulate individualised treatment plans.

Curative options include:

• Surgical resection: Removal of the tumour when liver function is well preserved and the tumour is localised.
• Liver transplantation: The ideal treatment for small HCCs within accepted criteria, such as Milan or UCSF criteria, offering both a cure for the cancer and treatment of the underlying cirrhosis.
• Radiofrequency ablation or microwave ablation: Minimally invasive techniques that destroy the tumour with heat and are suitable for small lesions.

For intermediate-stage disease, TACE, or Trans-Arterial Chemoembolisation, delivers chemotherapy directly to the tumour while cutting off its blood supply, providing effective tumour control. Advanced HCC is now treated with systemic therapies, including targeted agents and immunotherapy, which have improved survival significantly in recent years.

Prevention: The Best Strategy

The most effective strategy against HCC is prevention. Vaccination against Hepatitis B, treatment of chronic viral hepatitis, reduction of alcohol intake, and management of metabolic risk factors all reduce the likelihood of developing cirrhosis and, consequently, liver cancer.

For patients already at risk, regular surveillance is essential. Liver cancer is not a death sentence when caught early. At Apollo Hospitals, our commitment is to find it early through vigilant surveillance, rapid diagnosis, and advanced treatment.